Printer Friendly

Browse Pharmaceutical industry topic

Product development subtopic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Merck Provides Update on Phase 2 Clinical Trial of Once-Weekly Investigational Combination of MK-8507 and Islatravir for the Treatment of People Living with HIV-1. Nov 24, 2021 1676
Follow-Up Data from Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age. Nov 23, 2021 567
Amzell, in Collaboration with Amring Pharmaceuticals, Say Lead Product Has Entered Phase III Clinical Trial in the US for Treatment of Infantile Epileptic Disease. Nov 22, 2021 280
Good news for mildly infected COVID patients. Nov 21, 2021 755
Merck COVID pill backed for EU emergency use. Nov 20, 2021 535
New Analyses of Two AZD7442 COVID-19 Phase III Trials in High-Risk Populations Confirm Robust Efficacy and Long-Term Prevention. Nov 19, 2021 801
Late-Breaking Phase 2 Data for Investigational Oral Factor XIa Inhibitor Milvexian Suggest Favorable Antithrombotic Profile Across a Wide Range of Doses. Nov 16, 2021 152
Enanta Pharmaceuticals Reports Positive Final Data from its Phase 1b Studies of EDP-514, a Novel Hepatitis B Virus Core Inhibitor. Nov 15, 2021 929
Clinical trials of Egypt-developed anti-COVID-19 vaccine dubbed 'Covivax' to begin Nov. 14. Egypt Today staff Nov 13, 2021 172
Regeneron announces single dose of REGEN-COV provides long-term protection against COVID-19 in Phase 3 trial. Nov 9, 2021 241
Regeneron announces single dose of REGEN-COV provides long-term protection against COVID-19 in Phase 3 trial. Nov 9, 2021 240
Pfizer says COVID pill 89% effective against severe disease. Nov 6, 2021 630
Eli Lilly says Jardiance reduced cardiovascular death in Phase III study. Nov 5, 2021 169
Koneksa extends collaboration with Sanofi for central nervous system clinical trials. Nov 4, 2021 159
Koneksa extends collaboration with Sanofi for central nervous system clinical trials. Nov 4, 2021 158
4 vaccine makers submit EUA application for COVID-19 vaccine booster shot---PH FDA. Nov 3, 2021 529
Bahrain set for new drug trial. Nov 3, 2021 615
Immunic enrols first psoriasis patient IMU-935 trial. Oct 28, 2021 182
Immunic enrols first psoriasis patient IMU-935 trial. Oct 28, 2021 183
Gilead and Merck to begin Phase 2 clinical study of islatravir and lenacapavir. Oct 26, 2021 170
US Merck Touts Positive Top-Line Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily Oral Fixed Dose Combination of Doravirine/Islatravir for the Treatment of People with HIV-1 Infection. Oct 26, 2021 638
Arrowhead Files for Regulatory Clearance to Begin Phase 1/2a Study of ARO-C3 for Treatment of Complement Mediated Diseases. Oct 26, 2021 400
Posjtive Day.90 Data For First Patient In Trial Or Type 1 Diabetes Treatment. Oct 25, 2021 707
Phase 2 Trial Data Of Progressive MS Treatment Presented. Oct 25, 2021 600
Regeneron, Sanofi announce second Dupixent Phase 3 trial meets primary endpoint. Oct 25, 2021 351
Merck's Doravirine/Islatravir meets primary endpoints in Phase 3 trials. Oct 25, 2021 262
Phase III study indicates high efficacy of Pfizer/BioNTech COVID-19 booster shot. Oct 21, 2021 184
Pfizer, BioNTech Post Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine. Oct 21, 2021 583
Phase III study indicates high efficacy of Pfizer/BioNTech COVID-19 booster shot. Oct 21, 2021 183
Vertex Touts Positive Day 90 Data for the First Patient in the Phase 1/2 Clinical Trial Dosed With VX-880, a Novel Investigational Stem Cell-Derived Therapy for the Treatment of Type 1 Diabetes. Oct 19, 2021 883
Valneva reports positive Phase III results of COVID-19 vaccine candidate. Oct 18, 2021 155
Valneva reports positive Phase III results of COVID-19 vaccine candidate. Oct 18, 2021 154
Vertex announces data on 1st type 1 diabetes patient dosed in VX-880 trial. Oct 18, 2021 197
Results expected soon for Taiwan trials of COVID-19 vaccine combinations. Oct 15, 2021 257
Pfizer seeks US authorization of COVID vaccine for ages 5-11. Oct 8, 2021 673
Booster approved for senior, those at high risk. Oct 4, 2021 571
DOH closely monitoring developments on Molnupiravir trials. Oct 3, 2021 328
A pill to treat COVID-19 After trial shows it cut deaths, hospitalizations in half, experts want to get it approved for use quickly. Carolyn Y. Johnson The Washington Post Oct 2, 2021 1167
Merck's COVID pill hailed after cutting hospitalizations by 50%. Oct 2, 2021 665
Clinical trial suggests Merck's COVID-19 drug cuts risk of death and hospitalisation by 50%. Oct 1, 2021 227
Clinical trial suggests Merck's COVID-19 drug cuts risk of death and hospitalisation by 50%. Oct 1, 2021 226
Arrowhead Pharmaceuticals Initiates Phase 2b Study of ARO-APOC3 for Treatment of Mixed Dyslipidemia. Oct 1, 2021 455
FDA approves first twice-yearly antipsychotic for schizophrenia. Brooks, Megan Oct 1, 2021 628
Results of large US trial of AstraZeneca's COVID-19 vaccine indicates 74% efficacy. Sep 30, 2021 215
Results of large US trial of AstraZeneca's COVID-19 vaccine indicates 74% efficacy. Sep 30, 2021 214
Janssen Pharmaceutical starts phase three EVERGREEN study for Investigational Respiratory Syncytial Virus Vaccine. Sep 30, 2021 250
Janssen Pharmaceutical starts phase three EVERGREEN study for Investigational Respiratory Syncytial Virus Vaccine. Sep 30, 2021 251
Pfizer Touts Positive Top-line Results of Phase 3 Study Exploring Coadministration of Prevnar 20 With Seasonal Flu Vaccine in Older Adults. Sep 30, 2021 435
J&J's Janssen announces start of Phase 3 trial of RSV vaccine in older adults. Sep 29, 2021 161
Topline Results from Shionogi Phase 2 Study in Japan Show Akili's Digital Treatment Was Well-received and Improved Inattention Symptoms in Children with ADHD. Sep 29, 2021 807
Sanofi drops plans for own mRNA COVID-19 vaccine candidate despite positive Phase I/II interim results. Sep 28, 2021 179
Sanofi drops plans for own mRNA COVID-19 vaccine candidate despite positive Phase I/II interim results. Sep 28, 2021 178
Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults. Sep 27, 2021 538
ADC Therapeutics Doses First Patient in Phase 1 Clinical Trial of ADCT-901 in Advanced Solid Tumors. Sep 27, 2021 312
Sanofi reports Libtayo Phase 3 trial met primary, key secondary endpoints. Sep 20, 2021 228
AstraZeneca presents updated results from CASPIAN Phase III trial. Sep 19, 2021 373
AstraZeneca presents results from head-to-head DESTINY-Breast03 Phase III trial. Sep 19, 2021 331
AstraZeneca presents data from Phase II DESTINY-Lung01 trial of ENHERTU. Sep 19, 2021 221
Merck presents full results from pivotal Phase 3 KEYNOTE-826 trial. Sep 19, 2021 322
Merck presents first results from Phase 3 KEYNOTE-716 trial. Sep 19, 2021 166
AstraZeneca's ENHERTU showed 'clinically meaningful' response in Phase II trial. Sep 17, 2021 236
Gritstone announces dosing of patient in Phase 2 clinical trial of SLATE. Sep 17, 2021 421
AstraZeneca presents results from COAST trial at ESMO. Sep 17, 2021 425
Anebulo Pharmaceuticals Completes Manufacturing of ANEB-001 Capsules for Upcoming Phase 2 Clinical Trial. Sep 13, 2021 319
AstraZeneca discloses 'positive' high-level results in Phase III trials of PT027. Sep 9, 2021 192
Sanofi says Phase 3 PEGASUS trial did not meet primary, key secondary endpoints. Clinical report Sep 9, 2021 208
AstraZeneca announces MANDALA, DENALI trials met primary endpoints. Sep 9, 2021 223
AstraZeneca announces results from POSEIDON Phase III trial. Sep 9, 2021 423
Hutchmed and AstraZeneca initiate Phase III trial of combination for lung cancer. Sep 8, 2021 158
Amgen announces new data from pivotal NAVIGATOR Phase 3 trial. Sep 5, 2021 334
Astellas Provides Update on ASPIRO Clinical Trial of AT132 in Patients with X-linked Myotubular Myopathy. Sep 2, 2021 364
Astellas Provides Update on ASPIRO Clinical Trial of AT132 in Patients with X-linked Myotubular Myopathy. Sep 2, 2021 365
Pfizer begins Phase 3 clinical trial in adults for RSV vaccine. Sep 2, 2021 164
Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus. Clinical report Sep 2, 2021 535
Can-Fite Completes Patient Enrollment in Phase III Psoriasis Study. Sep 2, 2021 484
SK bioscience and GSK announce adjuvanted COVID-19 vaccine candidate Phase 3 trial commencement. Sep 1, 2021 303
Johnson & Johnson and global partners announce phase 2b Imbokodo HIV vaccine clinical trial results. Sep 1, 2021 329
SK bioscience and GSK announce adjuvanted COVID-19 vaccine candidate Phase 3 trial commencement. Sep 1, 2021 302
Johnson & Johnson and global partners announce phase 2b Imbokodo HIV vaccine clinical trial results. Sep 1, 2021 328
Merck, Ridgeback Biotherapeutics Initiate Pivotal Phase 3 MOVe-AHEAD Study Evaluating Molnupiravir for Post-Exposure Prophylaxis of COVID-19 Infection. Sep 1, 2021 545
The Recent Updates on Approaches and Clinical Trials Status of Covid-19 Vaccines Developed Globally. Chaudhary, Sachin; Shorbagi, Abdel-Nasser El-; Gupta, Ramesh Kumar; Kumar, Amit Report Sep 1, 2021 6784
Positive Top-Line Results from Pfizer's Phase 3 JADE DARE Trial Comparing the Efficacy of Abrocitinib and Dupilumab for Moderate to Severe Atopic Dermatitis. Aug 31, 2021 514
SK bioscience, GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate. Aug 31, 2021 154
Bayer Starts Phase III Clinical Development Program OASIS with Investigational Product, Elinzanetant. Aug 31, 2021 420
Pfizer says Phase 3 JADE DARE trial met co-primary, key secondary endpoints. Aug 30, 2021 214
Eli Lilly announces publication of EMPEROR-Preserved Phase III trial results. Aug 30, 2021 342
Merck: VAXNEUVANCE met key endpoints in Phase 3 trial. Aug 25, 2021 235
LATEST COMPANY NEWS. Aug 25, 2021 15928
Lexicon's sotagliflozin shows cardiovascular benefits in two trials. Aug 23, 2021 180
AstraZeneca: AZD7442 reduced development of symptomatic Covid in trial. Aug 20, 2021 210
Alexion discontinues Ultomiris Phase III trial based on IDMC recommendation. Aug 20, 2021 163
AZD7442 PROVENT Phase III Prophylaxis Trial Met Primary Endpoint in Preventing COVID-19. Aug 20, 2021 905
Adagene announces third clinical trial collaboration with Merck. Aug 19, 2021 196
Werewolf Therapeutics announces clinical trial collaboration with Merck. Aug 18, 2021 169
Enanta Pharmaceuticals Doses First Subject in a Phase 1 Clinical Study of EDP-721, Its Oral Hepatitis B Virus RNA Destabilizer. Aug 17, 2021 401
Eli Lilly says ADvocate 1, ADvocate 2 trials met primary and secondary endpoints. Aug 16, 2021 432
Imbrium Therapeutics Exercises Option with PureTech Health to Develop and Commercialize a Non-Opioid Interstitial Cystitis/Bladder Pain Syndrome Treatment. Aug 12, 2021 335
Domestic Covivac vaccine toA recruit volunteers for phase 2A clinical trials. Aug 10, 2021 505
SK Bioscience's COVID-19 vaccine candidate to enter phase 3 clinical trial. Aug 10, 2021 198
AstraZeneca announces Enhertu demonstrated superiority over T-DM1 in trial. Aug 9, 2021 152
Pfizer Touts Positive Top-Line Results from Phase 2b/3 Trial of Ritlecitinib in Alopecia Areata. Aug 5, 2021 843
Pfizer reports 'positive' results from Phase 2b/3 trial of ritlecitinib. Aug 4, 2021 248
Regeneron: NEJM publishes 'positive' Phase 3 trial results for REGEN-COV. Aug 4, 2021 167
Novartis announces lift of partial clinical trial hold on intrathecal OAV-101. Aug 3, 2021 252
Oral drug relieves symptoms of postpartum depression. Baulkman, Jaleesa Aug 1, 2021 696
Vertex to Initiate Phase 3 Development Program for New Once-Daily Triple Combination Regimen in People with Cystic Fibrosis. Jul 29, 2021 555
Vertex Pharmaceuticals to initiate Phase 3 program for VX-121/tezacaftor/VX-561. Jul 28, 2021 185
Russia approves trials of combined AstraZeneca/Sputnik V vaccine. Jul 27, 2021 210
Russia approves trials of combined AstraZeneca/Sputnik V vaccine. Jul 27, 2021 211
Adagene announces clinical trial collaboration with Merck. Jul 22, 2021 258
Merck Presents New Data from Ongoing Phase 2a Clinical Trial Evaluating the Safety, Tolerability and Pharmacokinetics of Investigational, Once-Monthly, Oral Islatravir for HIV-1 Prevention. Jul 21, 2021 664
Merck says islatravir 'well tolerated versus placebo' in Phase 2a trial. Jul 20, 2021 155
Vertex starts Phase 2 POC study in acute pain following bunionectomy surgery. Jul 19, 2021 216
Alexion Touts Positive Topline Results from Phase 3 Study of Ultomiris in Adults with Generalized Myasthenia Gravis. Jul 19, 2021 410
Vertex Initiates Phase 2 Clinical Trial Program for VX-548 for the Treatment of Acute Pain. Jul 19, 2021 482
eFFECTOR Therapeutics announces publication of tomivosertib preclinical data. Jul 16, 2021 173
Merck reports 'positive' event-free survival data from Phase 3 KEYNOTE-522 study. Jul 15, 2021 337
Incyte says 'positive' Phase 3 REACH3 study data published in NEJM. Jul 14, 2021 240
Merck Presents Interim Results from Phase 2/3 Studies of Molnupiravir, an Investigational Oral Antiviral Therapeutic for Mild to Moderate COVID-19. Jul 13, 2021 351
DESTINY-Gastric04 Head-to-Head Phase 3 Trial of Enhertu Initiated in Patients with HER2 Positive Advanced Gastric Cancer. Jul 12, 2021 707
PureTech Inks Clinical Trial and Supply Agreement with BeiGene to Evaluate LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid Tumors. Jul 8, 2021 641
Sanofi and GSK get approval for late-stage trial of COVID-19 vaccine candidate in India. Jul 8, 2021 194
Sanofi and GSK get approval for late-stage trial of COVID-19 vaccine candidate in India. Jul 8, 2021 195
LATEST COMPANY NEWS. Jul 7, 2021 22907
Eli Lilly announces EMPEROR-Preserved trial meets primary endpoint. Jul 6, 2021 305
Arrowhead announces interim clinical data from AROHIF21001 cohorts. Clinical report Jul 6, 2021 354
New Alzheimer's drug welcomed. Jul 5, 2021 1463
GSK and Vir's sotrovimab shows promise in trial. Jul 5, 2021 652
Several antipsychotics are emerging that target negative symptoms of schizophrenia. Bosworth, Ted Jul 1, 2021 986
'Twincretin' meets primary endpoints in five pivotal trials. Zoler, Mitchel L. Jul 1, 2021 1328
Journey Medical enters agreement with Dr. Reddy's to develop DFD-29. Jun 30, 2021 172
Sellas Life Sciences reports data from ongoing Phase 1/2 study of GPS. Jun 30, 2021 568
Arrowhead Pharmaceuticals Initiates Phase 2b Study of Investigational ARO-ANG3 for Treatment of Mixed Dyslipidemia. Jun 30, 2021 365
Intellia, Regeneron announce interim data from Phase 1 study of NTLA-2001. Jun 27, 2021 440
AstraZeneca reports exenatide Phase 3 trial in adolescents met primary endpoint. Jun 25, 2021 170
Phase III Pivotal Trial of Once Weekly Exenatide in Adolescents aged 10-17 Shows Benefit for the Treatment of Type 2 Diabetes. Jun 25, 2021 262
S. Korea to give all-out support for phase 3 trials of homegrown COVID-19 vaccine candidates. Jun 25, 2021 298
ADC Therapeutics announces interim results from Phase 2 clinical trial of Cami. Jun 22, 2021 325
Aerie Pharmaceuticals Completes Enrollment of its first Phase 3 Clinical Trial of Netarsudil Ophthalmic Solution in Japan. Clinical report Jun 18, 2021 539
Novartis reports data from completed two-copy cohort of Phase 3 SPR1NT trial. Jun 18, 2021 242
Exelixis, Bristol-Myers enter supply agreement for STELLAR-002 trial. Jun 14, 2021 198
Novavax's COVID-19 vaccine found to be more than 90% effective in US clinical trial. Jun 14, 2021 293
Incyte receives FDA approval of extension of NDA review period for Ruxolitinib Cream for atopic dermatitis. Jun 14, 2021 191
Novavax's COVID-19 vaccine found to be more than 90% effective in US clinical trial. Jun 14, 2021 294
Incyte receives FDA approval of extension of NDA review period for Ruxolitinib Cream for atopic dermatitis. Jun 14, 2021 192
Pharmaxis progresses clinical trial in bone marrow cancer. Jun 11, 2021 381
Pharmaxis progresses clinical trial in bone marrow cancer. Jun 11, 2021 381
Novartis reports positive iptacopan phase II study results. Jun 11, 2021 210
Sanofi says Phase 3 data from CADENZA study met primary composite endpoint. Clinical report Jun 11, 2021 199
First Clinical Trial Application Authorization Received in the EU for its Phase 2 Study of NT-I7 and Opdivo. Jun 10, 2021 338
First Participant Randomized in Phase 2 Trial Evaluating Temanogrel in Coronary Microvascular Obstruction. Jun 8, 2021 254
Can-Fite to Initiate Phase IIb NASH Study with its Drug Candidate Namodenoson. Jun 4, 2021 469
ADC Therapeutics announces updated clinical data from Phase 2 LOTIS-2 trial. Jun 4, 2021 180
Novartis says tislelizumab met OS primary endpoint in esophageal cancer trial. Jun 4, 2021 194
Merck says Keytruda reduced risk of disease recurrence in Phase 3 trial. Jun 3, 2021 182
DOST eyes start of COVID-19 mixed vaccine clinical trial by July. Jun 3, 2021 206
Novartis announces primary analysis of pivotal Phase II ELARA trial of Kymriah. Jun 2, 2021 264
NIH announces start of Phase 1/2 trial evaluating mixed COVID vaccine schedules. Jun 1, 2021 299
Drug makers eye alternative to COVID vaccines. May 28, 2021 786
Novartis announces start of EMPATHY trial for ensovibep in COVID-19. May 27, 2021 205
Janssen Posts Updated Phase 1 Results for Teclistamab Suggesting Deep, Durable Responses in Patients with Heavily Pretreated Multiple Myeloma. May 25, 2021 639
Mexico to commence phase three trials of Sanofi and Walvax's COVID-19 vaccines. May 25, 2021 209
Mexico to commence phase three trials of Sanofi and Walvax's COVID-19 vaccines. May 25, 2021 208
Sensyne Health and Phesi sign development agreement with pharmaceutical company. May 24, 2021 166
Sensyne Health and Phesi sign development agreement with pharmaceutical company. May 24, 2021 165
Janssen's updated Phase 1 teclistamab results suggest 'durable' responses. May 24, 2021 177
Zai Lab announces first patient treated in Greater China in METIS Phase 3 trial. May 24, 2021 164
Pharm-Olam to enrol UK volunteers in Phase III COVID-19 vaccine study. May 21, 2021 165
Pharm-Olam to enrol UK volunteers in Phase III COVID-19 vaccine study. May 21, 2021 164
US Merck Touts Positive Topline Results from Phase 3 Pediatric Studies for Its V114 Investigational 15-valent Pneumococcal Conjugate Vaccine. May 21, 2021 1113
Incyte's ponatinib meets primary endpoint in Phase 2 trial for leukemia. May 20, 2021 227
Merck: V114 met primary endpoints in two trials of Phase 3 pediatric program. May 20, 2021 191
Eli Lilly announces SURPASS-4 clinical trial meets primary, secondary endpoints. May 20, 2021 301
Sanofi to present data from Phase 1 AMEERA-1 study at ASCO. May 20, 2021 308
AstraZeneca to present update on ph3 trial of LYNPARZA in early breast cancer. May 19, 2021 221
Medicago and GSK Touts Positive Interim Phase 2 Results for Adjuvanted COVID-19 Vaccine Candidate. May 18, 2021 610
Regeneron Phase 3 data shows REGEN-COV reduces risk of hospitalization, death. May 17, 2021 223
Regeneron, Sanofi Phase 3 data show Dupixent reduced asthma attacks in children. May 17, 2021 245
Novo Nordisk Phase 2 ziltivekimab trial met endpoints in kidney disease. May 17, 2021 284
Volunteers needed for booster jabs clinical trial; MUST BE 18-65 AND HAD FIRST DOSE OF PFIZER COVID-19 JAB. May 14, 2021 451
COVID-19 Lesson: New FDA Chief, When Chosen, Must Crack Down On Clinical Trial Transparency. May 14, 2021 935
Crispr, Vertex to present new clinical data on CTX001 at EHA 2021. May 12, 2021 216
Regeneron says 'positive' Phase 3 Libtayo results presented at ESMO plenary. May 12, 2021 225
Pfizer first to seek full approval for COVID-19 vaccine in US. May 10, 2021 973
AstraZeneca Imfinzi demonstrates OS benefit in POSEIDON trial for NSCLC. May 7, 2021 214
Genprex wins centralized Institutional Review Board approval for its Acclaim-1 clinical trial in non-small cell lung cancer. May 6, 2021 403
Genprex initiates site recruitment for Acclaim-2 clinical trial for its lung cancer drug REQORSA. May 5, 2021 254
New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials. May 4, 2021 619
CORONAVIRUS CRISIS 12-yr-olds to get jab; Kids' trial has 100% efficacy. MIKEY SMITH Political Correspondent May 3, 2021 231
Covid-19 vaccine: Govt awaiting data from Pfizer clinical trials conducted on adolescent recipients, says Khairy. Apr 26, 2021 287
Call for 4,000 volunteers as Valneva begins phase 3 trials of vaccine made in Livingston; The Covid-19 vaccine being made by Valneva in Livingston, West Lothian has entered phase 3 trials, with a call for 4,000 volunteers. Elsa Maishman Apr 26, 2021 413
AstraZeneca reports positive Phase III trial results for nirsevimab. Apr 26, 2021 171
AstraZeneca reports positive Phase III trial results for nirsevimab. Apr 26, 2021 169
AstraZeneca reports positive Phase III trial results for nirsevimab. Apr 26, 2021 170
Vertex announces NaV1.8 inhibitor advancing to Phase 2 clinical development. Apr 26, 2021 271
Vertex to Advance NaV1.8 Inhibitor to Phase 2 Clinical Development. Apr 26, 2021 508
Incyte, Lilly announce new analyses of BREEZE-AD5 Phase 3 clinical trial data. Apr 23, 2021 185
Valneva SE starts pivotal Phase three clinical trial of VLA2001. Apr 22, 2021 168
Valneva SE starts pivotal Phase three clinical trial of VLA2001. Apr 22, 2021 167
Bayer, RAGT agree to develop hybrid wheat seeds for European markets. Apr 21, 2021 182
Eli Lilly, Incyte announce results from BRAVE-AA1 trial. Apr 20, 2021 404
Health minister: No need for phase 3 clinical trial volunteers to be inoculated again. Apr 19, 2021 275
Ideaya Biosciences announces data from ongoing darovasertib, binimetinib trial. Apr 16, 2021 512
GlaxoSmithKline and Merck discontinue trials involving feladilimab. Apr 15, 2021 155
TILT Biotherapeutics, MSD to Collaborate on Clinical Trial of Adenoviral Cancer Immunotherapeutic TILT-123 in Combination with Keytruda for Ovarian Cancer. Apr 15, 2021 365
Otsuka and Lundbeck announce decision to continue phase III clinical trial evaluating brexpiprazole for treatment of agitation in patients with Alzheimer's-type dementia. Apr 14, 2021 259
Otsuka and Lundbeck announce decision to continue phase III clinical trial evaluating brexpiprazole for treatment of agitation in patients with Alzheimer's-type dementia. Apr 14, 2021 258
Otsuka, Lundbeck to Continue Phase III Clinical Trial Evaluating Brexpiprazole for Treatment of Agitation in Patients with Alzheimer's-type Dementia. Apr 14, 2021 504
Lundbeck and Otsuka proceed with full phase III trial of brexpiprazole for agitation in Alzheimer's dementia. Apr 13, 2021 227
Zealand Pharma and Boehringer Ingelheim to conduct Phase 2 trials of BI 456906 in obesity and NASH. Apr 13, 2021 166
Lundbeck and Otsuka proceed with full phase III trial of brexpiprazole for agitation in Alzheimer's dementia. Apr 13, 2021 228
Zealand Pharma and Boehringer Ingelheim to conduct Phase 2 trials of BI 456906 in obesity and NASH. Apr 13, 2021 167
Lundbeck and Otsuka proceed with full phase III trial of brexpiprazole for agitation in Alzheimer's dementia. Apr 13, 2021 226
Zealand Pharma and Boehringer Ingelheim to conduct Phase 2 trials of BI 456906 in obesity and NASH. Apr 13, 2021 165
Antengene doses first patient in ATG-008 phase two trial. Apr 12, 2021 176
Antengene doses first patient in ATG-008 phase two trial. Apr 12, 2021 177
Phase 3 trial of diabetes drug Farxiga showed it did not help hospitalised COVID-19 patients. Apr 12, 2021 256
Phase 3 trial of diabetes drug Farxiga showed it did not help hospitalised COVID-19 patients. Apr 12, 2021 255
Company Shares Positive Topline Data In Phase 2 Study Of MS Treatment. Apr 12, 2021 685
US Merck Touts Positive Phase 3 Data Showing Keytruda Offering Superior Disease-Free Survival Compared with Placebo as Adjuvant Therapy in Patients with Renal Cell Carcinoma Following Surgery. Apr 9, 2021 472
Novavax initiates cross-over clinical trial with COVID-19 NVX-CoV2373 vaccine candidate. Apr 7, 2021 284
Novavax initiates cross-over clinical trial with COVID-19 NVX-CoV2373 vaccine candidate. Apr 7, 2021 285
Phase 1/2 Trial Initiated for Daiichi Sankyo's Menin Inhibitor DS-1594 in Patients with Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia. Apr 7, 2021 905
Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover. Apr 6, 2021 532
Ionis Pharmaceuticals commences phase three clinical trial of ALS drug ION363. Apr 6, 2021 207
Novavax begins COVID-19 vaccine clinical trial crossover arms to ensure all participants have access to active vaccine candidate. Apr 6, 2021 302
Novavax commences crossover arms in two COVID-19 vaccine clinical trials. Apr 6, 2021 159
Ionis Pharmaceuticals commences phase three clinical trial of ALS drug ION363. Apr 6, 2021 206
Novavax begins COVID-19 vaccine clinical trial crossover arms to ensure all participants have access to active vaccine candidate. Apr 6, 2021 301
Novavax commences crossover arms in two COVID-19 vaccine clinical trials. Apr 6, 2021 158
Phase 2 Trial of Enhertu Initiated in Patients with HER2 Overexpressing Advanced Colorectal Cancer. Apr 6, 2021 745
Oxford Astrazeneca vaccine trial on children paused due to a possible link to rare blood clots; The Oxford-Astrazeneca vaccine trial on children has been paused as the UK regulator investigates a potential link to rare blood clots in adults. Hannah Brown Apr 6, 2021 223
Novavax initiates COVID-19 vaccine clinical trial crossover. Apr 5, 2021 278
Alcon offers a new answer to dreaded spring allergies. Apr 5, 2021 569
Pharmaxis announces world-first clinical trial of wound and burn scars prevention treatment. Medical condition overview Apr 1, 2021 406
Pharmaxis announces world-first clinical trial of wound and burn scars prevention treatment. Medical condition overview Apr 1, 2021 406
WHO adds Janssen vaccine to list of safe and effective emergency tools against COVID-19. Apr 1, 2021 559
Genprex to present preclinical data for lung cancer drug REQORSA at American Association for Cancer Research meeting. Mar 31, 2021 415
Clinical trial results reveal Pfizer/BioNTech COVID-19 vaccine is 100% effective in 12 to 15 year olds. Mar 31, 2021 315
Clinical trial results reveal Pfizer/BioNTech COVID-19 vaccine is 100% effective in 12 to 15 year olds. Mar 31, 2021 314
Merck Receives Positive EU CHMP Opinion for Updated Label of Keytruda to Include Results of Phase 3 KEYNOTE-361 Trial in Certain Adult Patients with Locally Advanced or Metastatic Urothelial Cancer. Mar 31, 2021 350
Lilly, Vir biotechnology and GSK Tout Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with VIR-7831 in Low-Risk Adults with COVID-19. Mar 30, 2021 947
Phase IV Adempas Data Published in The Lancet Respiratory Medicine. Mar 30, 2021 234
Eli Lilly, Vir, GSK announces topline data from Phase 2 BLAZE-4 trial. Mar 29, 2021 305
GlaxoSmithKline to support manufacture of Novavax' COVID-19 vaccine in UK. Mar 29, 2021 190
Labuan completes second dose, phase one of Covid-19 immunisation programme. Mar 28, 2021 282
AstraZeneca Touts Positive Safety and Efficacy Data from US Phase III Primary Analysis of COVID-19 Vaccine. Mar 25, 2021 959
Sarah is first patient to trial new cancer treatment offering hope. LISA O'BRIEN lisa.obrien@mnamedia.co.uk Mar 25, 2021 465
BioPharmaceuticals and AstraZeneca's vaccine well tolerated in AZD1222 US Phase III trial, with no safety concerns. Mar 25, 2021 269
BioPharmaceuticals and AstraZeneca's vaccine well tolerated in AZD1222 US Phase III trial, with no safety concerns. Mar 25, 2021 270
AstraZeneca reports reduced efficacy of 76% in U.S. Phase III Covid trial. Mar 24, 2021 251
Ideaya announces dose expansion of Phase 1/2 study of IDE196/binimetinib. Mar 23, 2021 236
Pfizer initiates Phase 1 study of PF-07321332 in SARS-CoV-2. Mar 23, 2021 210
Novo Nordisk reports full results of STEP 4 trial were presented at ENDO meeting. Mar 23, 2021 173
Pfizer Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2. Mar 23, 2021 314
UPDATE: AstraZeneca to post more trial data amid US watchdog pressure. Mar 23, 2021 222
AstraZeneca US Phase III trial of AZD1222 Met Primary Efficacy Endpoint in Preventing COVID-19 at Interim Analysis. Mar 22, 2021 744
Incyte Shows Results from the Phase 3 DEVENT Study Evaluating Ruxolitinib as a Treatment for Patients with COVID-19 Associated Acute Respiratory Distress Syndrome on Mechanical Ventilation. Clinical report Mar 19, 2021 724
GlaxoSmithKline begins phase three study for severe asthma treatment. Mar 18, 2021 210
Takeda Pharmaceutical Company submits lanadelumab NDA with the Japanese Ministry of Health, Labour and Welfare for the treatment of hereditary angioedema. Mar 16, 2021 264
Gilead, US Merck to Jointly Develop and Commercialize Long-Acting, Investigational Treatment Combinations of Lenacapavir and Islatravir in HIV. Mar 16, 2021 969
Immutep enters second collaboration with Merck for Phase IIB trial in HNSCC. Mar 16, 2021 198
Pliant Therapeutics completes PLN-1474 Phase 1 study, transfer to Novartis. Report Mar 16, 2021 151
Medicago, GSK Start Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate. Mar 16, 2021 320
Takeda Pharmaceutical Company submits lanadelumab NDA with the Japanese Ministry of Health, Labour and Welfare for the treatment of hereditary angioedema. Mar 15, 2021 265
Companies make progress with COVID antibodies. Mar 15, 2021 1252
WHO approves J&J COVID vaccine. Mar 13, 2021 668
COVID-19 vaccine: A shot at redemption for J&J? Mar 13, 2021 667
Bamlanivimab, Etesevimab Combination Reduced Hospitalizations and Prevented Death in Phase 3 Trial for Early COVID-19. Mar 11, 2021 251
Novavax expects results of its Phase 3 COVID-19 vaccine trial in the US and Mexico in April 2021. Mar 10, 2021 262
Novavax expects results of its Phase 3 COVID-19 vaccine trial in the US and Mexico in April 2021. Mar 10, 2021 261
Iqvia Collaborating with Janssen Research and Development on Their Investigational COVID-19 Vaccine Trials. Mar 9, 2021 172
Iqvia Collaborating with Janssen Research and Development on Their Investigational COVID-19 Vaccine Trials. Mar 9, 2021 172
Novartis drug misses primary endpoint in lung cancer trial. Mar 9, 2021 157
Ridgeback Biotherapeutics and Merck report update on Phase 2a trial of investigational oral antiviral agent. Mar 8, 2021 241
Ridgeback Biotherapeutics and Merck report update on Phase 2a trial of investigational oral antiviral agent. Mar 8, 2021 242
Ridgeback Biotherapeutics, Merck Release Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir. Mar 8, 2021 620
Labuan completes first dose, phase one of immunisation programme. Mar 8, 2021 339
Canada approves Johnson & Johnson COVID-19 vaccine. Mar 6, 2021 545
Regeneron reports positive phase 2 data from REGN1908-1909 study. Mar 1, 2021 233
Merck & Co's gefapixant new drug application accepted for review in US. Mar 1, 2021 206
Takeda treats patients under Phase 1/2 clinical trials of Novavax and Moderna COVID-19 vaccine candidates in Japan. Feb 24, 2021 300
Takeda treats patients under Phase 1/2 clinical trials of Novavax and Moderna COVID-19 vaccine candidates in Japan. Feb 24, 2021 296
GlaxoSmithKline and Sanofi to push ahead with phase II trial of Covid-19 vaccine. Feb 23, 2021 565
TOP NEWS: Sanofi, GSK Begin Covid Vaccine Candidate Phase Two Study. Feb 22, 2021 201
GSK and Sanofi commence new COVID-19 vaccine trial after setback in 2020. Feb 22, 2021 227
GSK and Sanofi commence new COVID-19 vaccine trial after setback in 2020. Feb 22, 2021 223
AstraZeneca Phase 3 Lynparza Trial To Move To Early Primary Analysis. Feb 17, 2021 195
Sanofi Injects EUR2.5 Million In French Clinical Trial Simulation Firm. Feb 16, 2021 159
Potential seen for Takeda lung cancer treatment. Feb 15, 2021 537
Glenmark gets FDA approvals. Feb 15, 2021 642
Children to get Oxford dose in trial. ALEXANDER BRITTON Feb 14, 2021 161
Children to get Oxford dose in trial. ALEXANDER BRITTON Feb 14, 2021 160
WHO approves AstraZeneca vaccines for COVID variants, people aged over 65. Feb 11, 2021 684
Thailand to conduct Phase 1 clinical trials on locally produced Covid vaccine in March. Feb 11, 2021 325
4D pharma inks clinical trial collaboration and supply agreement with Merck and Pfizer. Feb 9, 2021 319
4D pharma Inks Clinical Trial Collaboration and Supply Agreement with Merck KGaA and Pfizer to Evaluate MRx0518 in Combination with BAVENCIO for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma. Feb 9, 2021 950
PH lucky to get vaccines that are potent vs new coronavirus variants, Galvez says. Feb 9, 2021 584
AstraZeneca says Imfinzi misses target in final stage head and neck cancer trial. Feb 6, 2021 363
AstraZeneca's Imfinzi fails to meet primary endpoint in head and neck cancer trial. Feb 5, 2021 192

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |